SOLIRIS®

(Eculizumab)

Documentation

Patented
Approved 2007
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Antagonist
Target: C5
Indication Category: Other

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA